Navigation Links
Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note
Date:11/9/2009

WOODCLIFF LAKE, N.J., Nov. 9 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has extended the expiration date and increased the purchase price of its previously announced "Modified Dutch Auction" tender offer, in which Par is offering to purchase, for cash, up to $65,000,000 aggregate principal amount, or up to approximately 82.7%, of its outstanding 2.875% Senior Subordinated Convertible Notes due 2010.

The price for the offer to purchase the convertible notes includes accrued and unpaid interest thereon up to, but not including, the date of purchase of the convertible notes, and has increased from a price (in multiples of $0.50 per $1,000 principal amount) not greater than $990.00 nor less than $982.50 per $1,000 principal amount to a price not greater than $1,000.00 nor less than $982.50 per $1,000 principal amount.

The deadline for tendering convertible notes in the offering has been extended from 12:00 midnight, New York City time, on Wednesday, November 11, 2009, to 12:00 midnight, New York City time, on Tuesday, November 24, 2009, unless further extended.

The Company has been advised that as of 5:00 p.m., New York City time, on November 6, 2009, approximately $4,345,000 of the convertible notes had been tendered in the Offer.

About Par Pharmaceutical

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press releases and other company information, visit www.parpharm.com.

Tender Offer Statement

This press release is for informational purposes only and is neither an offer to buy nor the solicitation of an offer to sell any securities. The full details of the tender of
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
2. ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
3. Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration
4. DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
5. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
7. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
8. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
9. Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
10. Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results
11. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... NEW YORK, Aug 20, 2014 Reportlinker.com ... available in its catalogue: Global Patient ... This report analyzes the worldwide markets ... following Product Segments: Floor Scales, Infant & Baby ... report provides separate comprehensive analytics for the US, ...
(Date:8/19/2014)... Aug. 19, 2014   Lincor Inc. ... experience technology to New Jersey ... agreement, CarePoint Health will deploy Lincor,s PatientLINC technology ... Christ Hospital and Hoboken University Medical Center. ... of software solutions to help hospitals reach new ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder ... present a scientific poster describing an innovative diagnostic procedure ... 2014: Shedding New Light on Disease (SPEC) conference in ... Dr. Treado,s poster entitled, "Development of in vitro Diagnostics ... will be discussed during the conference poster session on ...
Breaking Medicine Technology:Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2
... CINCINNATI, Ohio , June 29 Dr. Harry J. ... speaker and panel discussion participant at the 2010 Central Regional Meeting of ... June 16-19, 2010 .  The 2010 CeRMACS attracted over 400 participants and ... chemical disciplines.   , , ...
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems,Ltd. (Nasdaq: DHRM ), an emerging leader in the ... ,today announced members of its Executive Management will ring the NASDAQ Stock,Market closing bell ... , , ... , , ...
Cached Medicine Technology:Dr. Harry J. Guttman, Esq. Invited Speaker at 2010 Central Regional Meeting of the American Chemical Society 2Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell 2Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell 3
(Date:8/20/2014)... Caddis Partners LLC, has built one ... real estate company in recent years, developing or acquiring ... $500 million, including more than $100 million last year ... expansions into new geographic regions and a wider array ... pleased to announce an enhanced brand identity that includes ...
(Date:8/20/2014)... US (PRWEB) August 20, 2014 ... access, governmental and physician stakeholders networks impacting the ... Latin America, US, Canada, and Emerging Markets. , ... Heartbeat Experts’ perspectives on stakeholder management needs for ... new immunotherapy and targeted therapy investigational agents that ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 In its latest ... and alcohol treatment program that gets clients off to a ... they can believe in, is highlighting an important and possibly ... heeded by everyone who wants to understand the insidious nature ... of the belief that drug abuse targets a certain socioeconomic ...
(Date:8/20/2014)... August 20, 2014 The Academy of ... Lokhandwala, DDS, FAGD of Starbrite Dental in Fremont, California, ... 2014 Annual Meeting & Exhibits, which took place June ... presented to dentists who seek to provide the highest-quality ... earn this prestigious honor, Dr. Lokhandwala completed 500 hours ...
(Date:8/20/2014)... 20, 2014 (HealthDay News) -- White, straight women are ... minority, bisexual or lesbian women, a new study finds. ... women, aged 21 to 44, who took part in ... the National Survey of Family Growth study. In ... said they sought treatment for infertility. This ranged from ...
Breaking Medicine News(10 mins):Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Download HeartBeat Experts White Paper: A Stakeholder Engagement Strategy is Critical for the Evolving Melanoma Treatment Setting 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 3Health News:Fremont Dentist Receives Prestigious AGD Fellowship Award 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2
... Ames, Iowa Byron Brehm-Stecher, assistant professor in food ... his work with tiny particles. His latest research project ... silver nanoparticles to improve the safety of the worlds ... directly to foods, the ultimate goal of this project ...
... April 10 Clinsys Clinical Research, a,therapeutically ... launch of Clinsys ALTERNA, which utilizes its ... resource services. The new,division demonstrates Clinsys, commitment ... and the life sciences industry,s continuously evolving,staffing ...
... parents have taken their children to a podiatrist,for foot ... and foot pain bring thousands of adults to doctors, ... by the American,Podiatric Medical Association (APMA) during April,s Foot ... of foot,health when it comes to their children,s feet. ...
... The National,Community Pharmacists Association (NCPA) is endorsing Rep. ... 3rd,Congressional District, who has been a powerful advocate ... patients. He is facing a,challenger in the North ... RPh, executive vice president and CEO of NCPA ...
... April 10 Health Environments Research &,Design Journal ... is to enhance the knowledge and practice of,evidence-based ... trends, and translating research to practice. The,vision of ... result of enhancing,healthcare environments for those receiving and ...
... independent ... auditors, LOUISVILLE, Colo., ... a result of its first Type,II SAS 70 compliance audit. The SAS ... U.S. accounting firm over a,period of five months. The audit covered GHX,s ...
Cached Medicine News:Health News:Iowa State University researcher looks to use nanoparticles for food safety 2Health News:Clinsys(R) Redefines Resource Services with the Launch of Clinsys ALTERNA(TM) 2Health News:Pediatric Survey Reveals Many Parents Neglect Their Children's Feet 2Health News:The Center for Health Design & Vendome Group Unveil Premiere Issue of Health Environments Research & Design Journal (HERD) - http://www.herdjournal.com 2Health News:GHX Achieves SAS 70 Compliance 2
Bi-phasic peristaltic infusion pump for tumescent work....
Inquire...
... Pump provides optimum flow rate ... Operates on any voltage worldwide. ... safety Interlock and easy load ... Double Spike Tubing, Dual Pneumatic ...
... VASER System represents a major advance ... to cosmetic procedures. Combined with precision ... emulsification, a solid grooved probe design ... System has been designed to minimize ...
Medicine Products: